X-ray-based fragment screening has emerged as the most sensitive and effective method for identifying druggable sites. GIOS Biostructures aims to enable access to this technology by offering small-scale fragment screens, providing a cost-effective approach to assess the druggability of target proteins. Our screening platform is designed to uncover druggable sites, including cryptic pockets, which are often overlooked by conventional methods.